Revvity Inc.
RVTY Healthcare Diagnostics & Research
Revvity Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 3.67% from fiscal 2024. In the quarter to June 2026, revenue grew 1.31%, EPS grew 2.17%, free cash flow grew 59.3% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.
Follow RVTY
Revvity Inc. (RVTY) EV/FCF
As of 16 October 2026, Revvity Inc. (RVTY) trades at a EV/FCF of 34.0×. Over the past ten years it has ranged from −269× (December 2023) to 3,308× (January 2024); the current reading is higher than 67% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | 26.9× | (7.93%) |
| FY2024 | 29.2× | (99.11%) |
| FY2023 | 3,276× | 8,777.27% |
| FY2022 | 36.9× | 75.61% |
| FY2021 | 21.0× | (1.09%) |
| FY2020 | 21.2× | (52.49%) |
| FY2019 | 44.7× | 9.88% |
| FY2018 | 40.7× | 2.74% |
| FY2017 | 39.6× | 107.56% |
| FY2016 | 19.1× | (27.35%) |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Jun 2026 | 25.8× | 5.62% |
| Mar 2026 | 24.5× | (9.13%) |
| Dec 2025 | 26.9× | 6.88% |
| Sep 2025 | 25.2× | (7.72%) |
| 42 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| TWST Twist Bioscience Corporation compare | −85.1× |
| GH Guardant Health, Inc. compare | −83.1× |
| ICLR ICON PLC compare | 17.6× |
| DGX Quest Diagnostics Incorporated compare | 23.1× |
| QGEN QIAGEN N.V. compare | 23.5× |
| MEDP Medpace Holdings, Inc. compare | 24.1× |
| LH Labcorp Holdings Inc. compare | 30.8× |
| RVTY Revvity Inc. | 34.0× |
| CRL Charles River Laboratories International, Inc. compare | 45.4× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on RVTY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement